Assisted Reproductive Technology in the United States

In: New England Journal of Medicine · 2004 · vol. 350(16) , pp. 1603–1604 · doi:10.1056/nejmp048046 · PMID:15084692 · W2070471272
letter OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-08

In 1995, approximately 1.2 million US women sought infertility care annually, with fallopian tube obstruction and poor semen quality being leading causes, and ovulation induction drugs offering new hope.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Of the 60.2 million women in the United States who were of reproductive age in 1995, about 1.2 million, or 2 percent, had had an infertility-related medical appointment within the previous year, and about 15 percent had received infertility services at some time in their lives.1 Major causes of infertility in women include obstruction of the fallopian tubes, pelvic adhesions, endometriosis, and anovulation; the primary cause in men is poor semen quality.Two important developments in the past 50 years now provide hope for infertile couples. First, drugs have been developed that can induce ovulation in almost all anovulatory women . . .

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

References (4)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
unpaywall
last seen: 2026-09-23T06:15:37.550144+00:00
License: CC0 · commercial use OK